Private company

MaaT Pharma

Logo: MaaT Pharma, marque déposée, via Wikipedia⁴

MaaT Pharma is a French biotechnology company based in Lyon, founded in 2014.¹

MaaT Pharma, (parfois écrit Maat Pharma) est une entreprise française de l'industrie pharmaceutique et des biotechnologies, établie à² From the French Wikipedia, CC BY-SA 4.0

Last updated Oct 21, 2026.

Overview

2014Founded¹

Industrybiotechnology, pharmacy¹
HeadquartersLyon, France¹
Legal formpublic company¹
LEI969500CQQB6XUNW6CN97³
StatusActive³
LEI statusIssued and current³
Registered address70 AVENUE TONY GARNIER, 69007 Lyon, France³
Registered withNational Institute of Statistics and Economic Studies, 808370100³

See how the biggest companies compare on our leaderboards

Timeline

2014Founded Founded¹

Calendar

Drug trials and FDA: coming up

Oct 31, 2026Phase 2 trial readout expected Phase 2 trial of Pooled allogeneic fecal microbiotherapy in Transplant Complication: primary completion expected Oct 31, 2026 (ClinicalTrials.gov NCT05762211).⁵

Upcoming dates from Nasdaq's calendar; past results from the company's 8-K filings (Item 2.02). Trials from ClinicalTrials.gov, as the sponsor registered them (expected dates are the sponsor's own and often move); approvals and advisory committee meetings from the FDA. The FDA does not publish its decision (PDUFA) dates. The full markets calendar

Sources

The numbers on this page point here. Each one links to the record it came from.

1
WikidataMaaT Pharma on Wikidata
2
WikipediaMaaT Pharma on the French Wikipedia
3
GLEIFMaaT Pharma LEI record (969500CQQB6XUNW6CN97)
4
Wikimedia CommonsMaaT Pharma logo by MaaT Pharma, marque déposée
5
ClinicalTrials.govClinicalTrials.gov NCT05762211: Oral Pooled Fecal Microbiotherapy to Prevent Allogeneic Hematopoietic Cell Transplantation Complications (PHOEBUS Trial)